Navigation Links
Describe your invention, or your biotech patent may be worthless

The U.S. Supreme Court made a patent-law decision on Monday that could have multibillion-dollar ramifications for patent holders in the biotechnology sector.

The court denied an appeal in Univ. of Rochester v. G.D. Searle & Co. This effectively solidifies the decision that was made by the U.S. Court of Appeals for the Federal Circuit, which invalidate......

Full article >>> ned to be significant in the production and discovery of non-steroidal and anti-inflammatory drugs.

The University of Rochester ultimately received a patent (6,048,850) which covered methods for selectively inhibiting PGHS-2 activity in a human host, comprising administering a nonsteroidal compound that selectively inhibits activity of the PGHS-2 gene product to a human host in need of su......

Full article >>> med invention.

In the case of Noelle v. Lederman, the Federal Circuit decided that a patent for an antibody need not provide a written description of the antibody. However, provided that an application discloses a fully characterized antigen, the application may properly claim an antibody by its binding affinity to that described antigen. At first glance, this may appear to contra......

Full article >>> ication that fulfills the statutory requirements. An inventor may add additional description to the application, but it must then be filed as a separate child application. The problem with this procedure is that the new matter added would have a priority date of the child application and not of the parent.

For biotechnology related inventions a matter of days can translate into considerab......

Full article >>> those of the author, & do not necessarily reflect the views of The Wisconsin Technology Network, LLC. (WTN). WTN, LLC accepts no legal liability or responsibility for any claims made or opinions expressed herein.......

Full article >>>
'"/>

Source:wistechnology.com By Jonathan Fritz 12/01/04


Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Getting noticed in Genetown: Wisconsin biotech on display
4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
5. Wisconsin biotech firm receives $107K NIH grant
6. Manufacturing partnership will move into biotech and biomedical spaces
7. Wisconsin wont get Georgia biotech without a fight
8. The 10 biggest events shaping biotech in 2006
9. NimbleGen partners with UK biotech firm
10. 2006: A great biotech financing year, unless you were going public!
11. Big pharma seeks Wisconsin biotech partnerships
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):